CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $33,677,000 | -35.4% | 1,146,636 | +0.0% | 1.55% | -23.0% |
| Q2 2018 | $52,128,000 | -15.3% | 1,146,436 | -1.7% | 2.01% | -31.7% |
| Q1 2018 | $61,559,000 | -18.2% | 1,165,884 | -34.4% | 2.94% | -39.7% |
| Q4 2017 | $75,260,000 | +16.2% | 1,777,884 | +126.3% | 4.88% | -2.9% |
| Q3 2017 | $64,742,000 | +391.4% | 785,700 | +458.4% | 5.02% | +202.0% |
| Q2 2017 | $13,174,000 | -42.2% | 140,700 | -70.7% | 1.66% | -42.9% |
| Q1 2017 | $22,791,000 | – | 479,700 | – | 2.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |